Partnership & Pilot Programmes

Building responsible health-tech partnerships for preventative foot-health innovation.

PodAI Health Mobility UK is actively engaging established healthcare, care-home, podiatry, medical-device, telehealth and digital health organisations to explore partnership and pilot opportunities.

The goal is to develop a safe, scalable and compliant model for AI-assisted mobile foot-health screening and preventative care support in the UK.

Why Partnerships Matter

PodAI is being developed as a collaborative health-tech model. To deliver responsibly, the venture requires relationships with established organisations across healthcare delivery, technology, clinical oversight, compliance, patient access and care coordination.

Partnerships are important for:

• Market validation
• Clinical guidance
• Care-home access
• Technology integration
• Medical device supply
• Pilot testing
• Referral pathways
• Regulatory readiness
• Service improvement

Who We Want to Partner With

PodAI welcomes discussions with:

• Care-home operators
• Podiatry providers
• Private clinics
• GP-linked healthcare providers
• Diabetes-care organisations
• Medical-device manufacturers
• AI health-technology companies
• Telehealth platforms
• Remote monitoring providers
• International healthcare and medical tourism partners
• Research and innovation organisations

Partnership Opportunities

PodAI is open to exploring:

1. Care-Home Pilot Programmes

Collaboration with care homes to test mobile screening workflows and resident support models.

2. Podiatry and Clinical Partnerships

Referral, oversight, review and specialist collaboration with podiatry or healthcare professionals.

3. Medical Device Partnerships

Supplier or distributor relationships with manufacturers of suitable certified diagnostic and monitoring devices.

4. AI and Digital Health Integration

Collaboration with software, AI or telehealth companies to support reporting, remote communication and care coordination.

5. Market Validation Support

Letters of interest, pilot discussions, memoranda of understanding or non-binding collaboration statements.

6. International Healthcare Pathways

Exploring responsible links between screening, referral and healthcare access where specialist care may be needed.

What Partners May Gain

Partners may benefit from:

• Access to a proposed mobile preventative care model
• Collaboration in an emerging AI-assisted health-tech venture
• New community-based screening opportunities
• Improved resident or patient engagement
• Potential referral and service pathways
• Innovation visibility
• Market expansion opportunities

Pilot Programme Structure

A typical pilot discussion may include:

1. Introductory meeting
2. Review of service concept
3. Identification of target users
4. Operational and compliance assessment
5. Agreement on pilot scope
6. Screening workflow design
7. Reporting and feedback process
8. Review of outcomes and next steps

All pilot arrangements will be subject to regulatory readiness, commercial agreement, consent protocols, clinical governance and operational capacity.

Partnership Evidence for Stakeholders

PodAI is also engaging potential partners to demonstrate market interest, commercial relevance and practical validation. Non-binding letters of interest may help confirm that established organisations are open to discussing collaboration once the service is fully developed and compliant.